Advances in Hematologic Malignancies

The "Advances in Hematologic Malignancies" session at the 25th World Congress on Cancer and Diagnostics will focus on the latest breakthroughs in understanding and managing leukemia, lymphoma, and myeloma. Esteemed oncologists, hematologists, and researchers will present cutting-edge studies and clinical approaches, aiming to improve patient outcomes and provide insights into novel therapies and disease management strategies.

Key Topics:

  • Genomic Alterations in Hematologic Malignancies: Exploration of the latest discoveries in genetic mutations and their implications in disease pathogenesis and therapy.
  • Advances in Myeloma Research: Innovations in understanding the microenvironment of myeloma and new therapeutic targets.
  • Lymphoma Subtypes and Treatment Paradigms: Updates on Hodgkin's and non-Hodgkin's lymphomas, with a focus on novel treatments.

    Related Conference of Advances in Hematologic Malignancies

    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    April 07-08, 2025

    15th World Congress on Breast Cancer

    Vancouver, Canada
    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain

    Advances in Hematologic Malignancies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in